Skip to main content
. 2025 Oct 22;14(6):1899–1914. doi: 10.1007/s40122-025-00784-w

Table 4.

Responder rates for different efficacy parameters and their combinations in chronic migraine

Efficacy parameter Responder rate Significance vs. highest responder rate
MIDAS score reduced by ≥ 30% 48.2% p < 0.00001
HIT-6 score reduced by ≥ 5 points 55.0% p < 0.00001
Monthly migraine days reduced by ≥ 30% 58.2% p < 0.00001
MIDAS or migraine days 68.2% p = 0.0316
MIDAS or HIT-6 70.9%

n.s

p = 0.1264

HIT-6 or migraine days 71.8%

n.s

p = 0.1876

MIDAS or HIT-6 or migraine days 77.7%